DE69528984D1 - Hemmung der leukotrienbiosynthese mittels harnstoffderivaten - Google Patents

Hemmung der leukotrienbiosynthese mittels harnstoffderivaten

Info

Publication number
DE69528984D1
DE69528984D1 DE69528984T DE69528984T DE69528984D1 DE 69528984 D1 DE69528984 D1 DE 69528984D1 DE 69528984 T DE69528984 T DE 69528984T DE 69528984 T DE69528984 T DE 69528984T DE 69528984 D1 DE69528984 D1 DE 69528984D1
Authority
DE
Germany
Prior art keywords
biosynthesis
leukotria
inhibition
urine derivatives
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69528984T
Other languages
English (en)
Other versions
DE69528984T2 (de
Inventor
L Crooks
A Merrill
D Wightman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/455,643 external-priority patent/US5612377A/en
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Application granted granted Critical
Publication of DE69528984D1 publication Critical patent/DE69528984D1/de
Publication of DE69528984T2 publication Critical patent/DE69528984T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69528984T 1994-08-04 1995-07-14 Hemmung der leukotrienbiosynthese mittels harnstoffderivaten Expired - Fee Related DE69528984T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28601794A 1994-08-04 1994-08-04
US08/455,643 US5612377A (en) 1994-08-04 1995-05-31 Method of inhibiting leukotriene biosynthesis
PCT/US1995/007667 WO1996003983A1 (en) 1994-08-04 1995-07-14 Inhibition of leukotriene biosynthesis with urea derivatives

Publications (2)

Publication Number Publication Date
DE69528984D1 true DE69528984D1 (de) 2003-01-09
DE69528984T2 DE69528984T2 (de) 2003-09-04

Family

ID=26963530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528984T Expired - Fee Related DE69528984T2 (de) 1994-08-04 1995-07-14 Hemmung der leukotrienbiosynthese mittels harnstoffderivaten

Country Status (19)

Country Link
EP (1) EP0777471B1 (de)
JP (1) JPH10503771A (de)
AT (1) ATE228359T1 (de)
AU (1) AU685980B2 (de)
BR (1) BR9508521A (de)
CA (1) CA2196701A1 (de)
CZ (1) CZ287034B6 (de)
DE (1) DE69528984T2 (de)
DK (1) DK0777471T3 (de)
ES (1) ES2185708T3 (de)
FI (1) FI970452A (de)
HU (1) HUT76830A (de)
IL (1) IL114646A (de)
NO (1) NO315786B1 (de)
NZ (1) NZ290236A (de)
PL (1) PL180668B1 (de)
PT (1) PT777471E (de)
SK (1) SK282777B6 (de)
WO (1) WO1996003983A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
FR2880022B1 (fr) * 2004-12-24 2007-08-24 Mayoly Spindler Soc Par Action Nouveaux derives de la n-hydroxy-n'-phenyluree et de la n-hydroxy-n'-phenylthiouree et leur utilisation comme inhibiteurs de la synthese de la melanine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066658A (en) * 1988-11-10 1991-11-19 Ortho Pharmaceutical Corporation Substituted hydroxyureas
WO1990008545A1 (en) * 1989-02-01 1990-08-09 Abbott Laboratories Lipoxygenase inhibiting compounds
JP2528741B2 (ja) * 1991-01-09 1996-08-28 ファイザー製薬株式会社 オキサゾ―ル、チアゾ―ルおよびイミダゾ―ル化合物

Also Published As

Publication number Publication date
NO970477L (no) 1997-03-14
SK282777B6 (sk) 2002-12-03
FI970452A0 (fi) 1997-02-03
ATE228359T1 (de) 2002-12-15
IL114646A (en) 2000-02-29
CA2196701A1 (en) 1996-02-15
DE69528984T2 (de) 2003-09-04
EP0777471B1 (de) 2002-11-27
BR9508521A (pt) 1997-10-28
EP0777471A1 (de) 1997-06-11
PL318539A1 (en) 1997-06-23
NO315786B1 (no) 2003-10-27
SK11097A3 (en) 1997-09-10
PL180668B1 (pl) 2001-03-30
DK0777471T3 (da) 2003-03-17
FI970452A (fi) 1997-02-03
ES2185708T3 (es) 2003-05-01
CZ31297A3 (en) 1997-09-17
HUT76830A (en) 1997-11-28
JPH10503771A (ja) 1998-04-07
IL114646A0 (en) 1995-11-27
AU3091795A (en) 1996-03-04
CZ287034B6 (en) 2000-08-16
AU685980B2 (en) 1998-01-29
WO1996003983A1 (en) 1996-02-15
MX9700860A (es) 1997-10-31
PT777471E (pt) 2003-04-30
NO970477D0 (no) 1997-02-03
NZ290236A (en) 1998-12-23

Similar Documents

Publication Publication Date Title
DE69831868D1 (en) Antithrombosemittel
ATE297203T1 (de) Antithrombotische mitteln
DE69705829T2 (de) Meta-substituierte phenylsulphonamidderivate
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR0109703A (pt) Derivados de piperazina
DE69705300D1 (de) Cyclopropylalkansäurederivate
MY113733A (en) Salts of an anti-migraine indole derivative
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
AU5390900A (en) Potassium channel blocking agents
DE69132578T2 (de) Cephemderivate
DE69330601T2 (de) Serotoninergische ergolin derivate
RS50033B (sr) Derivati etansulfonil-piperidina
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee